- Country: Czech Republic
- Summary: Medicinal Product of Atc Group L04aa36 with the Active Substance Ocrelizumab
- CZT Ref No: 80643263
- Deadline: 03 Apr 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 167922-2023
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the public contract is the provision of continuous supplies of the medicinal product ATC group L04AA36 with the active substance ocrelizumab for a period of 2 years.
Doc Title: Pharmaceutical products
Contract Type: Supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMedicinal Product of Atc Group L04aa36 with the Active Substance Ocrelizumab - Czech Tender
The PARDUBICE REGION HOSPITAL, A.S., a Government sector organization in Czech Republic, has announced a new tender for Medicinal Product of Atc Group L04aa36 with the Active Substance Ocrelizumab. This tender is published on CzechTenders under CZT Ref No: 80643263 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-04-03.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
